Senior Director, Health Policy and Reimbursement at Hologic, Inc.
Danielle Scelfo is Senior Director, Health Policy and Reimbursement for Hologic Incorporated and is based out of their diagnostic headquarters in San Diego, California. An experienced industry veteran, Ms. Scelfo has chaired the Reimbursement and Policy Workgroup for the Coalition for 21st Century Medicine, co-chaired the Diagnostics Workgroup for the California Healthcare Institute and is a member of the two leading US diagnostic trade associations, AdvaMed Dx and the American Clinical Lab Association.
Ms. Scelfo has a comprehensive understanding of the US diagnostic industry, Medicare and Medicaid programs, and managed care delivery systems. Her extensive knowledge of government and commercial reimbursement policies and procedures lends valuable insights to the financial impact of reimbursement policy, legislation, and the regulatory rule-making process in healthcare. Ms. Scelfo has led efforts resulting in several successful coverage and payment policies for oncology therapeutics and advanced personalized diagnostic payment reform. Ms. Scelfo’s current responsibilities include representing Hologic in corporate reimbursement strategy, government affairs, coding, and payment of new technologies by payors.
From idea inception to commercialization, more and more start-ups are looking to large companies for strategic partnerships. This panel will explore the fundamental aspects needed to forge mutually beneficial relationships with large partners, such as collaborations, investments, licensing opportunities and in some cases M&A. Seasoned executives will share their perspective on the importance of relationships […]